Skip to main content
. 2022 Aug 4;12(34):21690–21703. doi: 10.1039/d2ra03240f

Apoptosis flow cytometric profiling upon treatment of HepG2 cancer cells with (F2).

Sample Normal Apoptosis Necrosis
Early Late
Non-treated Control 98.67 ± 1.04 0.46 ± 0.08 0.26 ± 0.04 0.61 ± 0.05
DOX-SAL/TPP+-g-CS NPs (F2) 72.59 ± 1.36 3.62 ± 0.51 14.25 ± 0.79 9.54 ± 0.39